The pathogenesis of atherosclerosis:a perspective for the1990s

The metabolic syndrome and risk of major coronary eventsin the Scandinavian Simvastatin Survival Study(4S)and the AirForce/Texas Coronary Atherosclerosis Prevention Study

Should C-reactive protein beadded to metabolic syndrome and to assessment of global cardio-vascular risk?

Serum lipoprotein(a)levels in patients with diabetic foot lesions

Relation of C-reac-tive protein to features of the metabolic syndrome in normal glu-cose tolerant,impaired glucose tolerant,and newly diagnosed type2 diabetic subjects

Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women:a report from the Women's Ischemia Syndrome Evaluation

Markers of inflammation and cardiovasculardisease application to clinical and public health practice A statementfor healthcare professionals from the Centers for Disease Controland Prevention and the American Heart Association

Lipoprotein(a) is an independent risk factor for periph-eral arterial disease in Chinese type 2 diabetic patients in Taiwan

Inflammatory pathways in atherosclerosis and acute coro-nary syndromes

Hy-perglycemia-induced production of acute phase reactants in adiposetissue

Follow-up report on the diagnosis of diabetes mellitus

Effect of increasing metabolic syndrome score onatherosclerotic risk profile and coronary artery disease angiographic severity

Clinical usefulness of very high and verylow levels of C-reactive protein across the full range of FraminghamRisk Scores

Clinical application of C-reactive protein for cardiovas-cular disease detection and prevention

CDC/AHA workshop on markers of inflammationand cardiovascular disease:Application to clinical and public healthpractice laboratory tests available to assess inflammation-perfor-mance and standardization

C-reactive protein,themetabolic syndrome,and risk of incident cardiovascular events:an8-year follow-up of 14719 initially healthy American women

C-reactive protein is an independent predictor of risk for the devel-opment of diabetes in the west of Scotland coronary preventionstudy

C-reactive protein as a cardiovascular risk factor:more than an epiphenomenon?

Atherosclerosis-an inflammatory disease.

Associations of C-reactive protein with mea-sures of obesity, insulin resistance, and subclinical atherosclerosis inhealthy, middle-aged women

Association of the metabolic syndrome with history of myocardialinfarction and stroke in the Third National Health and NutritionExamination Survey

Association between fastingglucose and C-reactive protein in a Japanese population:the Minohstudy

Association between fasting glucose and C-reactive proteinin middle-aged subjects

A pro-spective study of lipoprotein(a) and risk of coronary heart diseaseamong women with type 2 diabetes